Delivery Order SPE2DB20D3103-SPE2DB21FQ1N7
- Not listed
- This federal contract award, valued at $2,384.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,232,723 units of Doxycycline Hyclate 100 mg tablets, a common antibiotic medication. The contract is a Firm Fixed Price Delivery Order with a performance period through May 14, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $2,214.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX15D1113|SPE2DX25FBJMF) for the supply of 4,568,073,068 units of Doxycycline Hyclate 100 mg tablets. The contract is a firm fixed-price arrangement with an ultimate completion date of April 30, 2025. This award is not designated as a set-aside contract,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,568,481,151 units of doxycycline hyclate 100 mg tablets, at a ceiling value of $2,252.64. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 10, 2025. It is not set aside for any small business designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,400.24 Firm Fixed Price delivery order is for the supply of 1,000 units of Doxycycline Hyclate 100 mg tablets. The contract has an ultimate completion date of June 13, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide 4,561,973,653 units of Doxycycline Hyclate 100 mg tablets. The $24,715.00 firm fixed-price delivery order has an ultimate completion date of August 15, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,324.65 and is a delivery order with a firm fixed price pricing type. The contract is for the supply of 4,567,254,166 units of Doxycycline Hyclate 100 mg tablets, a pharmaceutical product used in medical treatment. The contract has an ultimate completion date of February 13, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,884.24 Delivery Order contract is for the supply of 4,564,479,977 units of Doxycycline Hyclate 100 mg tablets. The contract has a Firm Fixed Price pricing type and an ultimate completion date of May 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $2,446.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,718,880 units of Doxycycline Hyclate 100 mg tablets. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 1,000 units of doxycycline hyclate 100 mg tablets. The contract, valued at $1,063.89, is a delivery order contract with a firm fixed price and an ultimate completion date of July 2, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,229 units of Doxycycline Hyclate 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,541.40 and a period of performance ending on July 24, 2024. This award is not designated as a set-aside contract. Amerisourcebergen has been awarded numerous federal contracts by various agencies,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ1N7Delivery Order
This federal contract award, valued at $2,216.90, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Doxycycline Hyclate 100 mg tablets to support DLA Troop Support Medical programs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award reviewed is a delivery order issued under this overarching IDC. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/3/21 |